4
Changes in Ownership
Calidi Biotherapeutics, Inc. Filed Acc 0001493152-24-024597
Options or other derivatives
- CEO and Chairman of the Board acquired 40,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Camaisa Allan CEO and Chairman of the Board | 2024-06-17 | Grant or award · Stock Options (right to buy) | +40,000 | 40,000 | D | ||
Loading xslF345X05/ownership.xml…